R Squared Ltd Takes Position in Aemetis, Inc $AMTX

R Squared Ltd acquired a new stake in shares of Aemetis, Inc (NASDAQ:AMTX) during the second quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor acquired 11,985 shares of the specialty chemicals company’s stock, valued at approximately $30,000.

A number of other large investors have also recently added to or reduced their stakes in AMTX. Ethic Inc. bought a new position in Aemetis during the 2nd quarter valued at $42,000. Vanguard Personalized Indexing Management LLC boosted its stake in Aemetis by 48.7% during the 2nd quarter. Vanguard Personalized Indexing Management LLC now owns 19,611 shares of the specialty chemicals company’s stock valued at $49,000 after acquiring an additional 6,420 shares during the last quarter. Clear Harbor Asset Management LLC boosted its stake in Aemetis by 31.0% during the 2nd quarter. Clear Harbor Asset Management LLC now owns 21,950 shares of the specialty chemicals company’s stock valued at $54,000 after acquiring an additional 5,200 shares during the last quarter. State of Wyoming bought a new position in Aemetis during the 1st quarter valued at $90,000. Finally, Wellington Management Group LLP boosted its stake in Aemetis by 142.2% during the 1st quarter. Wellington Management Group LLP now owns 62,995 shares of the specialty chemicals company’s stock valued at $110,000 after acquiring an additional 36,983 shares during the last quarter. 27.02% of the stock is currently owned by institutional investors.

Analyst Upgrades and Downgrades

A number of research analysts have commented on the stock. Ascendiant Capital Markets increased their price objective on shares of Aemetis from $20.00 to $21.00 and gave the company a “buy” rating in a research note on Monday, October 6th. Weiss Ratings reiterated a “sell (e+)” rating on shares of Aemetis in a research note on Friday. Finally, UBS Group increased their target price on shares of Aemetis from $2.20 to $3.00 and gave the stock a “buy” rating in a report on Monday, June 30th. Three research analysts have rated the stock with a Buy rating and one has assigned a Sell rating to the company’s stock. Based on data from MarketBeat.com, Aemetis currently has a consensus rating of “Moderate Buy” and a consensus target price of $17.33.

Aemetis Stock Up 2.0%

AMTX stock opened at $2.57 on Monday. Aemetis, Inc has a fifty-two week low of $1.22 and a fifty-two week high of $4.73. The firm’s 50-day simple moving average is $2.53 and its 200 day simple moving average is $2.28. The stock has a market cap of $162.53 million, a PE ratio of -1.59 and a beta of 1.68.

Aemetis (NASDAQ:AMTX) last released its quarterly earnings data on Thursday, August 7th. The specialty chemicals company reported ($0.41) earnings per share for the quarter, missing analysts’ consensus estimates of ($0.35) by ($0.06). The company had revenue of $52.24 million for the quarter, compared to analyst estimates of $78.68 million. Equities analysts forecast that Aemetis, Inc will post -2.07 EPS for the current fiscal year.

Insider Transactions at Aemetis

In related news, Director Francis P. Barton sold 26,452 shares of the stock in a transaction dated Thursday, August 14th. The shares were sold at an average price of $2.53, for a total value of $66,923.56. Following the completion of the transaction, the director owned 208,518 shares in the company, valued at $527,550.54. This represents a 11.26% decrease in their position. The sale was disclosed in a filing with the SEC, which is available at this hyperlink. 15.90% of the stock is owned by corporate insiders.

Aemetis Profile

Aemetis, Inc operates as a renewable natural gas and renewable fuels company. It operates through three segments: California Ethanol, California Dairy Renewable Natural Gas, and India Biodiesel. The company focuses on the operation, acquisition, development, and commercialization of technologies to produce low and negative carbon intensity renewable fuels that replace fossil-based products.